Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RL

Ralf Lutterbüse — 26 Patents

AMAmgen: 25 patents #74 of 2,867Top 3%
MAMicromet Ag: 6 patents #3 of 65Top 5%
Munich, DE: #241 of 11,432 inventorsTop 3%
Overall (All Time): #150,017 of 4,157,543Top 4%
26 Patents All Time
Ralf Lutterbüse has been granted 26 US patents while listed as an inventor at Amgen. The first was granted in 2006 and the most recent in October 2025. Ralf Lutterbüse ranks #150,017 of 4,157,543 US inventors in our database (top 3.6%). Patent records list Ralf Lutterbüse in Munich, DE.

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12441796 Antibody constructs for CDH19 and CD3 Shengdong Xiao, Zhiyu Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2025-10-14
12435139 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2025-10-07
12304952 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2025-05-20
12297292 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Peter Kufer, Patrick Hoffmann +3 more 2025-05-13
12281172 Cross-species-specific PSMAxCD3 bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffmann, Doris Rau +6 more 2025-04-22
11987633 Cross-species-specific single domain bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffmann, Matthias Klinger +2 more 2024-05-21
11926666 Bispecific antibody constructs for CDH3 and CD3 Bertram Weiss, Anna-Lena Frisk, Ruprecht Zierz, Peter Kufer, Tobias Raum +6 more 2024-03-12
11661462 Optimized cross-species specific bispecific single chain antibody contructs Benno Rattel, Matthias Friedrich, Peter Kufer, Patrick Hoffmann, Tobias Raum +3 more 2023-05-30
11591396 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2023-02-28
11498964 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2022-11-15 $332,140,000
11472886 Cross-species-specific PSMAxCD3 bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffmann, Doris Rau +6 more 2022-10-18
11028171 Bispecific antibody constructs for CDH3 and CD3 Bertram Weiss, Ann-Lena Frisk, Ruprecht Zierz, Peter Kufer, Tobias Raum +6 more 2021-06-08
10981998 Cross-species-specific single domain bispecific single chain antibody Peter Kufer, Tobias Raum, Roman Kischel, Patrick Hoffman, Matthias Klinger +2 more 2021-04-20
10851170 Antibody constructs for CD70 and CD3 Tobias Raum, Claudia Blümel, Wibke Deisting, Patrick Hoffmann, Elisabeth Nahrwold +2 more 2020-12-01 $297,944,000
10683351 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2020-06-16
10294300 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Peter Kufer +2 more 2019-05-21
10059766 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2018-08-28 $239,480,000
9982063 Pharmaceutical compositions with resistance to soluble CEA Petra Fluhr, Evelyne Schaller, Doris Rau, Susanne Mangold, Peter Kufer +3 more 2018-05-29
9765157 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Peter Kufer, Patrick Hoffmann +3 more 2017-09-19
9695250 Pharmaceutical compositions with resistance to soluble CEA Petra Fluhr, Evelyne Schaller, Doris Rau, Susanne Mangold, Peter Kufer +3 more 2017-07-04
8394926 Pharmaceutical compositions with resistance to soluble CEA Petra Mayer, Evelyne Schaller, Doris Rau, Susanne Mangold, Peter Kufer +3 more 2013-03-12
8101722 Less immunogenic binding molecules Peter Kufer, Ulla Lenkkeri-Schütz, Birgit Kohleisen 2012-01-24 $12,064,000
7635472 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders Peter Kufer, Birgit Kohleisen, Steven Zeman, Patrick Bauerle 2009-12-22 $6,790,000
7575923 CD19xCD3 specific polypeptides and uses thereof Bernd Dorken, Gert Riethmuller, Peter Kufer, Ralf Bargou, Anja Löffler 2009-08-18 $5,927,000
7435549 Method of identifying binding site domains that retain the capacity of binding to an epitope Peter Kufer, Tobias Raum, Katrin Borschert, Florian Zettl 2008-10-14 $4,886,000